Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Marina Papoutsaki
Observed names:
M Papoutsaki,
M. Papoutsaki,
Papoutsaki, Marina
Institutions:
National and Kapodistrian University of Athens,
Andreas Sygros Hospital
Observed institutions:
University of Rome Tor Vergata,
National and Kapodistrian University of Athens,
Andreas Sygros Hospital,
Heinrich Heine University Düsseldorf
ORCID:
0000-0002-2422-0994
Observed ORCID:
0000-0002-2422-0994
OpenAlex ID:
A5036267976
Adalimumab for severe psoriasis and psoriatic arthritis: An open-label study in 30 patients previously treated with other biologics
2007
·
Marina Papoutsaki
, Maria-Sole Chimenti
, et al.
·
Journal of the American Academy of Dermatology
·
130
Drug Survival of Interleukin (IL)‑17 and IL‑23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi‑country, Multicentric Cohort Study
2022
·
Tiago Torres
, Luis Puig
, et al.
·
American Journal of Clinical Dermatology
·
95
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study
2024
·
Tiago Torres
, Andrea Chiricozzi
, et al.
·
American Journal of Clinical Dermatology
·
86
PDF
The tumor suppressor activity of IKKα in stratified epithelia is exerted in part via the TGF-β antiproliferative pathway
2008
·
Barbara Marinari
, Francesca Moretti
, et al.
·
Proceedings of the National Academy of Sciences
·
68
The Impact of Treatment with IL-17/IL-23 Inhibitors on Subclinical Atherosclerosis in Patients with Plaque Psoriasis and/or Psoriatic Arthritis: A Systematic Review
2023
·
Aikaterini Tsiogka
, Stamatios Gregoriou
, et al.
·
Biomedicines
·
61
PDF
Treatment of Psoriasis and Psoriatic Arthritis
2013
·
Marina Papoutsaki
, Antonio Costanzo
·
BioDrugs
·
57
Treatment of erythrodermic psoriasis with etanercept
2006
·
M. Esposito
, A. Mazzotta
, et al.
·
British Journal of Dermatology
·
56
A p38-dependent pathway regulates ΔNp63 DNA binding to p53-dependent promoters in UV-induced apoptosis of keratinocytes
2005
·
Marina Papoutsaki
, Francesca Moretti
, et al.
·
Oncogene
·
55
IKKα Is a p63 Transcriptional Target Involved in the Pathogenesis of Ectodermal Dysplasias
2008
·
Barbara Marinari
, Costanza Ballaro
, et al.
·
Journal of Investigative Dermatology
·
54
Cross-Talks in the p53 Family: ΔNp63 is an Anti-Apoptotic Target for ΔNp73α and p53 Gain of Function Mutants
2006
·
Mauro Lanza
, Barbara Marinari
, et al.
·
Cell Cycle
·
48
PDF
Etanercept for the treatment of severe childhood psoriasis
2005
·
M. Papoutsaki
, A. Costanzo
, et al.
·
British Journal of Dermatology
·
46
Real‐world data from a single Greek centre on the use of secukinumab in plaque psoriasis: effectiveness, safety, drug survival, and identification of patients that sustain optimal response
2020
·
N. Rompoti
, P. Sidiropoulou
, et al.
·
Journal of the European Academy of Dermatology and Venereology
·
39
Brodalumab in plaque psoriasis: Real‐world data on effectiveness, safety and clinical predictive factors of initial response and drug survival over a period of 104 weeks
2022
·
Natalia Rompoti
, Maria Politou
, et al.
·
Journal of the European Academy of Dermatology and Venereology
·
36
Type III juvenile pityriasis rubra pilaris: a successful treatment with infliximab
2007
·
M Ruzzetti
, R Saraceno
, et al.
·
Journal of the European Academy of Dermatology and Venereology
·
36
Long‐term efficacy of adalimumab in generalized pustular psoriasis
2008
·
Arianna Zangrilli
, Marina Papoutsaki
, et al.
·
Journal of Dermatological Treatment
·
34
Molecular basis of basal cell carcinoma: Analysis of differential gene expression by differential display PCR and expression array
2003
·
Thomas Welss
, Marina Papoutsaki
, et al.
·
International Journal of Cancer
·
34
PDF
Infliximab in Psoriasis and Psoriatic Arthritis
2013
·
Marina Papoutsaki
, Filipa Osório
, et al.
·
BioDrugs
·
32
The Impact of Methodological Approaches for Presenting Long-Term Clinical Data on Estimates of Efficacy in Psoriasis Illustrated by Three-Year Treatment Data on Infliximab
2010
·
M. Papoutsaki
, M. Talamonti
, et al.
·
Dermatology
·
29
Safety and efficacy study on etanercept in patients with plaque psoriasis
2005
·
A. Costanzo
, A. Mazzotta
, et al.
·
British Journal of Dermatology
·
25
Adalimumab for the treatment of severe psoriasis and psoriatic arthritis
2008
·
Marina Papoutsaki
, Antonio Costanzo
, et al.
·
Expert Opinion on Biological Therapy
·
24
The p73 Gene Is an Anti-Tumoral Target of the RARβ/γ-Selective Retinoid Tazarotene
2004
·
Marina Papoutsaki
, Mauro Lanza
, et al.
·
Journal of Investigative Dermatology
·
23
PDF
HLA-C*06:02 Does Not Predispose to Clinical Response Following Long-Term Adalimumab Treatment in Psoriatic Patients: A Retrospective Cohort Study
2017
·
Marina Talamonti
, Marco Galluzzo
, et al.
·
Molecular Diagnosis & Therapy
·
21
Bullous Dermatomyositis: A Marker of Poor Prognosis and Aggressive Internal Malignancy?
2008
·
Arianna Zangrilli
, Marina Papoutsaki
, et al.
·
Acta Dermato Venereologica
·
21
PDF
Patient characteristics, treatment patterns and disease outcomes in patients with psoriatic arthritis followed in a combined Dermatology–Rheumatology clinic: a retrospective real-world study
2022
·
Kalliopi Klavdianou
, Maria Stavropoulou
, et al.
·
Rheumatology International
·
13
Bimekizumab in psoriasis: a monocentric study evaluating short- and mid-term effectiveness and safety profile in a real-world setting
2024
·
Natalia Rompoti
, Irene Stefanaki
, et al.
·
Archives of Dermatological Research
·
10
Show more works
View as search
Works count:
66
Citation count:
1,229
H-index:
21
I10-index:
25
Year
Topic
Type